ESC Premium Access

Prospective application of a risks-adjusted antithrombotic protocol in elderly patients treated with the last generation of everolimus-eluting stents. The SIERRA-75 (EPIC-05) registry

Presentation

About the speaker

Doctor Jose Maria De La Torre Hernandez

H. Marques de Valdecilla, Santander (Spain)
0 follower

133 more presentations in this session

Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.

Speaker: Doctor M. Verdoia (Biella, IT)

Thumbnail

Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Thumbnail

Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age

Speaker: Professor F. Abdullayev (Baku, AZ)

Thumbnail

Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)

Thumbnail

Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study

Speaker: Doctor I. Lozano Martinez-Luengas (Gijon, ES)

Thumbnail

Access the full session

Interventional Cardiology ePosters

Speakers: Doctor J. De La Torre Hernandez, Doctor M. Verdoia, Associate Professor D. Maximkin, Professor F. Abdullayev, Assistant Professor V. Veulemans...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy

29 August 2021

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

27 August 2021

ESC Premium Access

Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation

27 August 2021

This platform is supported by

logo Novo Nordisk